CN105833039A - 一种针对阴虚体质的保健品及其制备方法 - Google Patents
一种针对阴虚体质的保健品及其制备方法 Download PDFInfo
- Publication number
- CN105833039A CN105833039A CN201610206794.6A CN201610206794A CN105833039A CN 105833039 A CN105833039 A CN 105833039A CN 201610206794 A CN201610206794 A CN 201610206794A CN 105833039 A CN105833039 A CN 105833039A
- Authority
- CN
- China
- Prior art keywords
- yin
- parts
- health product
- deficiency
- deficiency constitution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000031971 Yin Deficiency Diseases 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 26
- 239000004575 stone Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 abstract description 13
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 206010022437 insomnia Diseases 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 206010001928 Amenorrhoea Diseases 0.000 abstract description 6
- 206010010774 Constipation Diseases 0.000 abstract description 6
- 208000009205 Tinnitus Diseases 0.000 abstract description 6
- 231100000886 tinnitus Toxicity 0.000 abstract description 6
- 208000002173 dizziness Diseases 0.000 abstract description 5
- 210000003127 knee Anatomy 0.000 abstract description 5
- 206010029410 night sweats Diseases 0.000 abstract description 5
- 230000036565 night sweats Effects 0.000 abstract description 5
- 201000001881 impotence Diseases 0.000 abstract description 4
- 206010036596 premature ejaculation Diseases 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 235000019789 appetite Nutrition 0.000 abstract description 3
- 230000036528 appetite Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 210000002700 urine Anatomy 0.000 abstract description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010006895 Cachexia Diseases 0.000 abstract 1
- 206010013774 Dry eye Diseases 0.000 abstract 1
- 206010013789 Dry throat Diseases 0.000 abstract 1
- 206010021033 Hypomenorrhoea Diseases 0.000 abstract 1
- 206010024552 Lip dry Diseases 0.000 abstract 1
- 241001280406 Mauremys mutica Species 0.000 abstract 1
- 206010027339 Menstruation irregular Diseases 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 208000026500 emaciation Diseases 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 10
- 230000007958 sleep Effects 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000000857 drug effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 210000002105 tongue Anatomy 0.000 description 3
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000005156 Dehydration Diseases 0.000 description 2
- 241001523681 Dendrobium Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- QSNCUGULHPBRGR-UHFFFAOYSA-N Dendramine Natural products CC12C3(O)CCC2CN(C)C1C1C(C(C)C)C3C(=O)O1 QSNCUGULHPBRGR-UHFFFAOYSA-N 0.000 description 1
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000004483 Dyspareunia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于营养品技术领域,具体涉及一种针对阴虚体质的保健品及其制备方法;本发明包括按照干重重量份计算的如下材料:石斛15~25份、西洋参5~15份、北沙参5~15份、石金钱龟板5~25份和鳖甲10~20份。本发明使用的材料取自特定地域,不仅安全无副作用,而且含有特定配比的化学成分,将其按一定的配比的进行混合,通过每种材料的功能药效进行搭配,产生协同作用,用于治疗调理腰膝酸软、头晕耳鸣、体型消瘦、盗汗、唇干咽燥热、尿短而黄、失眠多梦、饥不思食、眼睛干涩、便秘、月经不调或少经闭经、早泄、阳痿、三高、心烦、疲乏无力、脸长痘、面色无华等症状的阴虚体质有明显的疗效。
Description
技术领域
本发明属于营养品技术领域,具体涉及一种针对阴虚体质的保健品及其制备方法。
背景技术
阴虚,指精血或津液亏损的病理现象。多见于劳损久病或热病之后而致阴液内耗的患者。阴虚主症为五心烦热或午后潮热、盗汗、颧红、消瘦、舌红少苔等,阴虚者表现为阴津不足,身体呈缺水状态,以致眼干、鼻干、口干、皮肤粗糙、头发干枯等。其典型症状是心烦易怒、失眠多梦、头晕眼花、腰膝酸软、小便次多量少、心跳偏快、夜间盗汗、手足心发热、耳鸣等。
阴虚体质易感如下病:
1、阴虚内热的基本特征是干枯不滋润,有内热,舌干红、少苔,易得结核、肺痨或长期干咳。
2、失眠、耳鸣,健忘,两目干涩。
3、皮肤生斑。阴虚体质的人阴虚内热,火燥,干性皮肤比较多,面色晦暗,或出现较多色素斑或口腔溃疡反复发作的症状。
4、阴虚体质的人如果再有淤血倾向,比较容易生肿瘤。
5、阴虚体质的人即使形体很瘦,照样会血脂偏高,阴虚到一定程度,血液粘稠,就会得高血脂、高血压。
6、糖尿病初起阶段都是阴虚为主,表现为口干,饮不解渴,皮肤变薄变干。
7、便秘、尿少、尿黄赤。
8、妇女月经减少,或阴道干燥而性交疼痛等。月经通畅时表现为月经提前,如果阴虚比较严重的话,会出现闭经,叫血枯经闭。
9、形体消瘦,头发、皮肤干枯起皱。
10、耐冬不耐夏,视力减退较快,腰酸腿软。
其中,女性阴虚严重者可导致亡阴症,所以,阴虚也是必须引起重视,而需要进行治疗和调理的。
目前,在治疗阴虚的方法上,主要是靠中医进行调理,但是中医调理不仅慢而且治疗效果都不是十分显著。
发明内容
为了解决上述问题,本发明的目的在于提供一种针对阴虚体质的保健品,不仅能快速调理,而且效果显著无副作用。
本发明的目的之二是提供了所述针对阴虚体质的保健品的制备方法。
本发明是通过以下技术方案来实现的:
一种针对阴虚体质的保健品,包括按照干重重量份计算的如下材料:
较佳地,包括按照干重重量份计算的如下材料:
较佳地,所述石斛为野生虎牙石斛;最优选产自老挝的野生虎牙石斛。石斛主要的成分为石斛多糖、石斛碱、石斛酚、石斛胺,总氨基酸,还有特殊的菲类、联苄类抗癌成分。特别是生长在老挝这种特殊地域(老挝地处北纬14~23度,东经100~108度年平均气温约26℃,年降水量1250毫米~3750毫米,亚热带、热带季风气候的国家)。其中所含多糖、氨基酸和无机元素的组成配比较其他地域生长的不同,石斛多糖含量高达34%(普通的为22%)。铁皮石斛含有17种氨基酸和7种无机元素,其中,铁皮石斛生品以谷氨酸、天冬氨酸、缬氨酸和亮氨酸为主要氨基酸,4种氨基酸占总氨基酸的56%。而悬浮培养的原球茎以谷氨酸、天冬氨酸和精氨酸为主要氨基酸,这3种氨基酸占总氨基酸的71%。谷氨酸、天冬氨酸的含量在野生品和原球茎中都比较高,在人体必需氨基酸中,两者都含有除色氨酸以外的全部人体必需氨基酸。其中,亮氨酸比例最高。其生长于悬崖峭壁之上,生长极为缓慢,能长成虎牙大小都是极品品质。配合本发明其他材料,药效相互协同,更能很好地提高人体免疫力、增强食欲、滋阴降火。
较佳地,所述西洋参为产自加拿大的西洋参。西洋参显著增食、增肥。达到静心凝神、消除疲劳、增强记忆力等作用,可适用于失眠、烦躁、记忆力衰退及老年痴呆等症状。可以抗心律失常、抗心肌缺血、抗心肌氧化、强化心肌收缩能力,冠心病患者症状表现为气阴两虚、心慌气短可长期服用西洋参,疗效显著。西洋参的功效还在于可以调节血压,可有效降低暂时性和持久性血压,有助于高血压、心律失常、冠心病、急性心肌梗塞、脑血栓等疾病的恢复。折叠促进血液活力、西洋参可以降低血糖、调节胰岛素分泌、促进糖代谢和脂肪代谢,对治疗糖尿病有一定辅助作用。本发明使用产自加拿大的西洋参,特殊地域配合本发明其他材料,药效相互协同,更能很好地提高其治疗失眠、烦躁、三高的药效。
较佳地,所述鳖甲为野生鳖甲;最优选产自马来西亚的野生鳖甲。主要含Cr、Mn、Cu、Zn、Fe、Se、Al多种人体必需微量元素,以及天冬氨酸、苏氨酸、蛋氨酸、赖氨酸等7种人体必需的氨基酸。尚含维生素D、碳酸钙、磷酸钙等化学成分。马来西亚因位于赤道附近,属于热带雨林气候和热带季风气候,无明显的四季之分,一年之中的温差变化极小,平均温度在26~30℃之间、全年雨量充沛,发明使用产自加拿大的西洋参,特殊地域配合本发明其他材料,药效相互协同,更能很好地发挥其用于阴虚潮热、骨蒸盗汗、或热病后期阴液耗伤、夜热早凉、以及热邪伤阴、阴虚风动、疒徵瘕积聚、肝脾肿大等症的治疗功效。
制备针对阴虚体质的保健品的方法,先将所述量的石斛、西洋参、北沙参、石金钱龟板和野鳖甲洗净烘干,然后分别磨碎,最后将磨碎的各个材料混合均匀封装,得到所述针对阴虚体质的保健品。较佳地,各个材料磨碎达到250~350目。
本发明使用的材料与传统的中药材有所区别,使用的材料取自特定地域,不仅都是安全无副作用,而且含有特定配比的化学成分,将其按一定的配比的进行混合,通过每种材料的功能药效进行搭配,产生协同作用,用于治疗调理腰膝酸软、头晕耳鸣、体型消瘦、盗汗、唇干咽燥热、尿短而黄、失眠多梦、饥不思食、眼睛干涩、便秘、月经不调或少经闭经、早泄、阳痿、三高、心烦、疲乏无力、脸长痘、面色无华等症状的阴虚体质有明显的疗效。
具体的实施方式
下面结合具体实施方式对本发明作进一步的详细说明,以助于本领域技术人员理解本发明。
实施例1
一种针对阴虚体质的保健品,包括按照干重重量份计算的如下材料:野生虎牙石斛(老挝)20份、西洋参(加拿大)10份、北沙参10份,石金钱龟板20份、野生鳖甲(马来西亚)15份。
制备所述针对阴虚体质的保健品的方法,先将所述量的野生虎牙石斛(老挝)、西洋参(加拿大)、北沙参,石金钱龟板和野生鳖甲净烘干,然后分别磨碎为250-300目粉末,最后将磨碎的各个材料混合均匀封装,得到所述针对阴虚体质的保健品的。
实施例2
一种针对阴虚体质的保健品,包括按照干重重量份计算的如下材料:野生虎牙石斛15份、西洋参15份、北沙参8份,石金钱龟板7份、野生鳖甲(马来西亚)20份。
制备方法,同实施例1。
实施例3
一种针对阴虚体质的保健品,包括按照干重重量份计算的如下材料:野生虎牙石斛(老挝)10份、西洋参8份、北沙参12份,石金钱龟板25份、野生鳖甲(马来西亚)10份。
制备方法,同实施例1。
实施例4
一种针对阴虚体质的保健品,包括按照干重重量份计算的如下材料:野生虎牙石斛(老挝)25份、西洋参5份、北沙参15份,石金钱龟板5份、野生鳖甲15份。
制备方法,同实施例1。
实施例5
一种针对阴虚体质的保健品,包括按照干重重量份计算的如下材料:野生虎牙石斛(老挝)17份、西洋参(加拿大)10份、北沙参10份,石金钱龟板10份、野生鳖甲(马来西亚)18份。
制备方法,同实施例1。
实施例6
一种针对阴虚体质的保健品,包括按照干重重量份计算的如下材料:野生虎牙石斛(老挝)20份、西洋参(加拿大)12份、北沙参5份,石金钱龟板18份、野生鳖甲(马来西亚)10份。
制备方法,同实施例1。
上述实施例,只是本发明的较佳实施例,并非用来限制本发明实施范围,故凡以本发明权利要求所述的特征及原理所做的等效变化或修饰,均应包括在本发明权利要求范围之内。
具体使用时,每次食用1-5克,每日1-3次。食用期间,禁忌同时食用煎炸、肥腻、生冷和辛辣食物。
病例1
某男,20岁,症状:失眠多梦、饥不思食、眼睛干涩、便秘、脸长痘。
食用:每次1克,每日两次。
食用1天后,正常大便,夜睡安稳。食用3天后:食欲大增,体重增长,无新痘增长。食用15天后:脸长痘逐渐开始消失。
病例2
某女:20岁,症状:便秘、脸长痘、少经闭经。
食用:每次1克,每日两次。
食用1天后:正常大便。食用3天后:无新痘增长。食用15天后:脸长痘逐渐开始消失,同时月经来。继续跟踪调查,后续几个月月经正常。
病例3
某男:32岁,症状:腰膝酸软、尿短而黄、早泄、阳痿。
食用:每次2克,每日两次。
食用2天后:面色红润;食用15天后:治愈。
病例4
某女:29岁,症状:眼睛干涩、失眠多梦、月经不调、疲乏无力。
食用:每次2克,每日两次。
食用1天后:夜睡安稳;食用3天后:不用任何眼药水的情况下无眼睛干涩,面色红润;食用15天后停:后续几个月月经正常。
病例5
某男:45岁,症状:腰膝酸软、头晕耳鸣、三高。
食用:每次2克,每日两次。
食用1天后:夜睡安稳;食用3天后:面色红润,无服用其他任何药物的情况下血压血糖明显下降。食用90天后:医院体检结果,三高回复正常水平。
从上述病例和食用后的效果来看,本发明腰膝酸软、头晕耳鸣、体型消瘦、盗汗、唇干咽燥热、尿短而黄、失眠多梦、饥不思食、眼睛干涩、便秘、月经不调或少经闭经、早泄、阳痿、三高、心烦、疲乏无力、脸长痘、面色无华等症状的阴虚体质有明显的疗效;以上病例只是一小部分,在此不一一列举。
Claims (9)
1.一种针对阴虚体质的保健品,其特征在于,包括按照干重重量份计算的如下材料:
2.如权利要求1所述针对阴虚体质的保健品,其特征在于,包括按照干重重量份计算的如下材料:
3.如权利要求1或2所述针对阴虚体质的保健品,其特征在于,所述石斛为野生虎牙石斛。
4.如权利要求3所述针对阴虚体质的保健品,其特征在于,所述野生虎牙石斛为产自老挝的野生虎牙石斛。
5.如权利要求1或2所述针对阴虚体质的保健品,其特征在于,所述西洋参为产自加拿大的西洋参。
6.如权利要求1或2所述针对阴虚体质的保健品,其特征在于,所述鳖甲为野生鳖甲。
7.如权利要求6所述针对阴虚体质的保健品,其特征在于,所述野生鳖甲为产自马来西亚的野生鳖甲。
8.制备权利要求1-7中任意一种所述针对阴虚体质的保健品的方法,其特征在于,先将所述量的石斛、西洋参、北沙参、石金钱龟板和野鳖甲洗净烘干,然后分别磨碎,最后将磨碎的各个材料混合均匀封装,得到所述针对阴虚体质的保健品。
9.如权利要求8所述制备针对阴虚体质的保健品的方法,其特征在于,各个材料磨碎达到250~350目。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610206794.6A CN105833039A (zh) | 2016-04-01 | 2016-04-01 | 一种针对阴虚体质的保健品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610206794.6A CN105833039A (zh) | 2016-04-01 | 2016-04-01 | 一种针对阴虚体质的保健品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105833039A true CN105833039A (zh) | 2016-08-10 |
Family
ID=56596801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610206794.6A Withdrawn CN105833039A (zh) | 2016-04-01 | 2016-04-01 | 一种针对阴虚体质的保健品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105833039A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104645026A (zh) * | 2014-12-19 | 2015-05-27 | 王大明 | 一种调节阴虚体质的泡脚粉及其制备方法 |
CN104839707A (zh) * | 2015-04-23 | 2015-08-19 | 劲膳美生物科技股份有限公司 | 阴虚体质非全营养配方食品 |
-
2016
- 2016-04-01 CN CN201610206794.6A patent/CN105833039A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104645026A (zh) * | 2014-12-19 | 2015-05-27 | 王大明 | 一种调节阴虚体质的泡脚粉及其制备方法 |
CN104839707A (zh) * | 2015-04-23 | 2015-08-19 | 劲膳美生物科技股份有限公司 | 阴虚体质非全营养配方食品 |
Non-Patent Citations (1)
Title |
---|
李宝印等: "艾颗胶囊在艾滋病发病期治疗中的临床观察", 《中华中医药学会防治艾滋病分会2014年学术会议论文集》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103416625B (zh) | 一种大麦型仔猪饲料及其制备方法 | |
CN101999647B (zh) | 功能含化阿胶系列产品及其制备方法 | |
CN101966271B (zh) | 一种治疗高血压的中药汤剂 | |
CN102823653A (zh) | 系列复方保健药膳奶片及其制备方法 | |
CN101574499A (zh) | 安神宁心胶囊 | |
CN103266040A (zh) | 美容保健酒 | |
CN110585371A (zh) | 一种健脾益气安神药食同源中药组合物和健脾益气安神膏的制备方法 | |
CN104922475A (zh) | 一种改善亚健康的铁皮石斛复方制剂及其制备方法 | |
CN103181434B (zh) | 一种舒心保健茶及其制备方法 | |
CN102423407B (zh) | 一种用于调理亚健康状态的中药组合物 | |
CN104107309A (zh) | 一种补肾保健汤 | |
CN103300197A (zh) | 一种助眠茶及其制作方法 | |
CN103584244B (zh) | 清热润肺饮料其制备方法 | |
CN102274425B (zh) | 一种改善睡眠质量的中药组合物 | |
CN104544008A (zh) | 一种黑芝麻补脑健脑汤料的配方及生产方法 | |
CN104825800B (zh) | 一种治疗失眠症的药物及其制备方法 | |
CN102526537A (zh) | 一种治疗高血糖的药物组合物 | |
CN100382832C (zh) | 一种用于改善女性更年期症状的保健食品 | |
CN105833039A (zh) | 一种针对阴虚体质的保健品及其制备方法 | |
CN103815348A (zh) | 一种刺玫果滋阴润燥火锅调料 | |
CN104687142A (zh) | 一种人参健脑安神汤料的配方及生产方法 | |
CN103830649B (zh) | 一种治疗慢性酒精中毒的药物及其制备方法 | |
CN102885956B (zh) | 一种助眠中药组合物及其制备方法 | |
CN106177437A (zh) | 一种改善女性阳虚体寒的玛咖组合物 | |
CN105455004A (zh) | 一种胃下垂患者食用的面条 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160810 |